[HTML][HTML] MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches
E Callegari, L Gramantieri, M Domenicali… - Cell Death & …, 2015 - nature.com
MicroRNAs (miRNAs) constitute a large class of short RNAs (eg, 20–24 nucleotides in
length), whose main function is to posttranscriptionally regulate the expression of protein …
length), whose main function is to posttranscriptionally regulate the expression of protein …
the management of hepatocellular carcinoma
R Cabrera, DR Nelson - Alimentary pharmacology & …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 31, 461–476 Summary Background Hepatocellular carcinoma is
the leading cause of death in cirrhosis. A majority of patients present at an advanced stage …
the leading cause of death in cirrhosis. A majority of patients present at an advanced stage …
Spon2 promotes m1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin–rho gtpase–hippo pathways
YL Zhang, Q Li, XM Yang, F Fang, J Li, YH Wang… - Cancer research, 2018 - AACR
Tumor-associated macrophages (TAM) represent key regulators of the complex interplay
between cancer and the immune microenvironment. Matricellular protein SPON2 is …
between cancer and the immune microenvironment. Matricellular protein SPON2 is …
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and …
BACKGROUND & AIMS: Sorafenib plus metronomic tegafur/uracil therapy can induce tumor
stabilization in advanced hepatocellular carcinoma (HCC) patients. This study evaluated the …
stabilization in advanced hepatocellular carcinoma (HCC) patients. This study evaluated the …
Hepatocellular carcinoma: insight from animal models
Y Li, ZY Tang, JX Hou - Nature reviews Gastroenterology & hepatology, 2012 - nature.com
Hepatocellular carcinoma (HCC) ranks as the third most common cause of death from
cancer worldwide. Although major risk factors for the development of HCC have been …
cancer worldwide. Although major risk factors for the development of HCC have been …
Targeted therapy for hepatocellular carcinoma
HC Spangenberg, R Thimme, HE Blum - … reviews Gastroenterology & …, 2009 - nature.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide.
The major etiologies and risk factors for development of HCC are well defined and some …
The major etiologies and risk factors for development of HCC are well defined and some …
[HTML][HTML] miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
W Mu, C Hu, H Zhang, Z Qu, J Cen, Z Qiu, C Li, H Ren… - Cell research, 2015 - nature.com
Liver and kidney cancers are notorious for drug resistance. Due to the complexity,
redundancy and interpatient heterogeneity of resistance mechanisms, most efforts targeting …
redundancy and interpatient heterogeneity of resistance mechanisms, most efforts targeting …
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB
Hepatocellular carcinoma (HCC) is a highly lethal malignancy mostly because of de novo
and acquired resistance to conventional chemotherapy. Constitutive activation of Akt and …
and acquired resistance to conventional chemotherapy. Constitutive activation of Akt and …
Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis
W Li, YH Tian, Y Liu, Z Wang, S Tang… - The Journal of …, 2016 - jstage.jst.go.jp
Platycodin D (PD), a major saponin derived and isolated from the roots of Platycodon
grandiflorum, exerts potent growth inhibition and strong cytotoxicity against various cancer …
grandiflorum, exerts potent growth inhibition and strong cytotoxicity against various cancer …
[HTML][HTML] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma Retraction in/10.3892/ijo. 2021.5280
K Liu, S Liu, W Zhang, B Ji… - … journal of oncology, 2014 - spandidos-publications.com
The miR‑222 cluster has been demonstrated to function as oncomiR in human
hepatocellular carcinoma (HCC). miR‑222 confers chemotherapy drug resistance in various …
hepatocellular carcinoma (HCC). miR‑222 confers chemotherapy drug resistance in various …